Enzo Biochem (NYSE:ENZ) Releases Earnings Results

Enzo Biochem (NYSE:ENZGet Free Report) released its quarterly earnings data on Monday. The medical research company reported ($0.02) earnings per share for the quarter, Zacks reports. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Enzo Biochem Trading Down 4.7 %

Shares of NYSE ENZ opened at $0.47 on Tuesday. The firm’s 50-day moving average price is $0.57 and its 200-day moving average price is $0.87. Enzo Biochem has a 1-year low of $0.41 and a 1-year high of $1.30.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a report on Saturday. They set a “hold” rating on the stock.

Check Out Our Latest Stock Report on ENZ

Enzo Biochem Company Profile

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Featured Articles

Earnings History for Enzo Biochem (NYSE:ENZ)

Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.